Fintel reports that on May 28, 2025, Jefferies downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) from Buy ...

Fintel reports that on May 28, 2025, Leerink Partners downgraded their outlook for Rocket Pharmaceuticals (NasdaqGM:RCKT) ...

Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on ...

FDA places clinical hold of RP-A501 for the treatment of patients with Danon disease due to a patient death. Click here to ...

Pharmaceutical granulation techniques continue to be developed and improved with modified / novel technologies and processing ...

Indian pharma works to offset hidden inefficiencies in R&D automating repetitive tasks: Nandita Vijayasimha, Bengaluru Friday, May 23, 2025, 08:00 Hrs [IST] Indian pharma has note ...

AGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy ...

BioMarin Pharmaceutical Inc., a biotechnology company ... an adeno associated virus vector for the treatment of severe hemophilia A. The company’s products under development include BMN 333 ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued ...

Dengue Vaccines Market Projected to Grow from USD 90 Million in 2025 to Nearly USD 200 Million by 2035The global Dengue Vaccines Market is expected to be reach USD 90.0 million in 2025 and is likely ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...